Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities
  • Price (USD)168.56
  • Today's Change0.00 / 0.00%
  • Shares traded689.00
  • 1 Year change+69.80%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 15:47 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

  • Revenue in USD (TTM)12.67bn
  • Net income in USD827.68m
  • Incorporated1994
  • Employees70.00k
  • Location
    DaVita Inc2000 16th StDENVER 80202-5158United StatesUSA
  • Phone+1 (310) 536-2668
  • Fax+1 (302) 636-5454
  • Websitehttps://www.davita.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DVA:NYQ since
announced
Transaction
value
Fresenius Medical Care AG & Co KGaA-Dialysis Clinic Network,BrazilAnnounced05 Mar 202405 Mar 2024Announced32.82%300.00m
Fresenius Medical Care AG & Co KGaA-Dialysis Clinic Network,EcuadorAnnounced05 Mar 202405 Mar 2024Announced32.82%--
Fresenius Medical Care AG & Co KGaA-Dialysis Clinic Network,ColombiaAnnounced05 Mar 202405 Mar 2024Announced32.82%--
Fresenius Medical Care AG & Co KGaA-Dialysis Clinic Network,ChileAnnounced05 Mar 202405 Mar 2024Announced32.82%--
Data delayed at least 15 minutes, as of Nov 26 2024.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.